Vol 7, No 2 (February 2015): Journal of Thoracic Disease (Atrial Fibrillation)

Review Article

Practical issues in the management of novel oral anticoagulants—cardioversion and ablation
Abhishek Maan, E. Kevin Heist, Jeremy N. Ruskin, Moussa Mansour
Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?
T. Jared Bunch, Michael J. Cutler
The role of rotors in atrial fibrillation
David E. Krummen, Vijay Swarup, Sanjiv M. Narayan
The role of transcription factors in atrial fibrillation
Mengchen Zhou, Yuhua Liao, Xin Tu
Hybrid approaches in atrial fibrillation ablation: why, where and who?
Kevin Driver, J. Michael Mangrum
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
Colleen M. Hanley, Peter R. Kowey
Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?
Tze-Fan Chao, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Fa-Po Chung, Jo-Nan Liao, Shih-Ann Chen
Adjunct ablation strategies for persistent atrial fibrillation—beyond pulmonary vein isolation
Silvia Magnani, Daniele Muser, William Chik, Pasquale Santangeli
Alternative medicine in atrial fibrillation treatment—Yoga, acupuncture, biofeedback and more
Arun Kanmanthareddy, Madhu Reddy, Gopi Ponnaganti, Hari Priya Sanjani, Sandeep Koripalli, Nivedita Adabala, Avanija Buddam, Pramod Janga, Thanmay Lakkireddy, Sudharani Bommana, Ajay Vallakati, Donita Atkins, Dhanunjaya Lakkireddy
Dysfunction of the autonomic nervous system in atrial fibrillation
Yutao Xi, Jie Cheng
Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives
Bin Kong, Yu Liu, He Huang, Hong Jiang, Congxin Huang
Surgical options in atrial fibrillation
Basel Ramlawi, Kareem Bedeir